Unresectable Skin Squamous Cell Carcinoma
5 clinical trials · Condition
◉ Watch Unresectable Skin Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer (NCT05896839) | National Cancer Institute (NCI) | 2024-07-24 |
| Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC (NCT05085496) | City of Hope Medical Center | 2022-04-19 |
| Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors (NCT05269381) | Mayo Clinic | 2022-03-31 |
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic (NCT02721732) | M.D. Anderson Cancer Center | 2016-08-15 |
Track Unresectable Skin Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.